On January 1, 2025, the ceiling in the high -cost protection for medicines was changed from SEK 2,850 to SEK 2,900 – which has led to criticism from pharmacy staff as well as the pensioners’ national organization, PRO.
– We see a clear risk that the elderly will be severely affected by the increase in high -cost protection. Drug use is greatest among the elderly and women, which makes these groups particularly vulnerable. Many elderly people have limited financial resources and the increased cost can force them to refrain from the necessary medication, which impairs their health and risks increasing costs in the long run, has PRO’s union secretary Christine Cars-singels Earlier, told News24.
Read more: The alarm: Pensioners do not pick up their medicines
Photo: Henrik Montgomery/TT
At the same time, a new report from the pharmacy’s European industry organization PGEU shows that the number of residual drugs in 2024 was as high as the record year 2023.
– We have reached an unacceptable status quo where the lack of drugs does not seem to be better or worse. Behind each deficiency stands a worried patient and a pharmacist who struggles to find solutions. We need political decisions that strengthen the supply of drugs and fully utilize the pharmacy’s competence, said Johan WallérCEO of the Swedish Pharmacy Association who is a member of PGEU, in a press release Last week.
Don’t miss: Medicines End for 4 out of 10: “Very worrying”
Therefore, there is a lack of asthma medicine
A group of drugs that have been listed for some time for some time is asthma medicine intended for children. When News24 asks the Swedish Medicines Agency what the shortage is due to responds Maria WanrudGroup Manager at the Medicines Accessibility Unit, like this:
– The companies that report the residual situations state various reasons such as unexpectedly high demand and transport or distribution-related causes.
Read more: New rules for pharmacies – you are affected as a customer
Photo: Carl-Olof Zimmerman/TT
Don’t miss: Then you should lock in your medication
This is how the forecast for the asthma medication looks now
Above all, there are inhalation sprays with fluticasone that there is a shortage of, including Flutide Evohaler, Icsori and Fluticasone Cipla.
What does the forecast look like when the lack of this type of drug can be over in Sweden?
– Fluticasone Cipla and Scori, according to Pronos, will be April or May, while Flutide Evohaler has reported that the residual situations will last asleep by 2025. However, Flutide Evohaler states that there will be partial deliveries of Flutide Evohaler, of both strengths, throughout the residual period, and they can thus, and they can thus Cover part of the market, replies Wanrud, who also emphasizes that the end date for residual listings is always a forecast and thus may change.
Read more: News Today – Current news from Sweden and the world
Don’t miss: Latest news – take part in what is happening right now